Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Xi Xiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9753-6586; OpenAlex author ID A5082088810. Sources: OpenAlex.

Their work

Papers
7 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 7

  1. Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. First author DOI 10.1186/s12967-024-05962-6↗
  2. Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy. Co-author DOI 10.1038/s41419-022-05503-3↗
  3. Inhibition of miR30a-3p by sulforaphane enhances gap junction intercellular communication in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.10.042↗
  4. Novel plant microRNAs from broccoletti sprouts do not show cross-kingdom regulation of pancreatic cancer. Co-author DOI 10.18632/oncotarget.27527↗
  5. MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. First author DOI 10.1016/j.canlet.2019.03.025↗
  6. Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer. First author DOI 10.1016/j.omto.2019.03.011↗
  7. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.01.038↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ingrid Herr · 6 shared papers, 2016–2022 · strength 0.59
  2. Christina Georgikou · 4 shared papers, 2019–2020 · strength 0.40
  3. Libo Yin · 4 shared papers, 2019–2020 · strength 0.40
  4. Svetlana Karakhanova · 3 shared papers, 2019–2020 · strength 0.29
  5. Li Liu · 3 shared papers, 2019–2020 · strength 0.29
  6. Yefeng Yin · 3 shared papers, 2016–2020 · strength 0.24
  7. Rongkun Li · 1 shared paper, 2024 · strength 0.23
  8. Jichun Gu · 1 shared paper, 2024 · strength 0.23
  9. Yishen Mao · 1 shared paper, 2024 · strength 0.23
  10. Chen Jin · 1 shared paper, 2024 · strength 0.23
  11. Hengchao Li · 1 shared paper, 2024 · strength 0.23
  12. Deliang Fu · 1 shared paper, 2024 · strength 0.23
  13. Yiqiao Luo · 2 shared papers, 2019 · strength 0.19
  14. Xuefeng An · 1 shared paper, 2022 · strength 0.14
  15. Michael Schaefer · 1 shared paper, 2022 · strength 0.14
  16. Li Liu · 1 shared paper, 2022 · strength 0.14
  17. Oliver Strobel · 1 shared paper, 2022 · strength 0.14
  18. Nathalie Bauer · 1 shared paper, 2016 · strength 0.05
  19. Clifford C. Nwaeburu · 1 shared paper, 2016 · strength 0.05
  20. Alia Abukiwan · 1 shared paper, 2016 · strength 0.05
  21. Peter Schemmer · 1 shared paper, 2016 · strength 0.05
  22. Prince Saforo Amponsah · 1 shared paper, 2016 · strength 0.05
  23. Pei Fan · 1 shared paper, 2016 · strength 0.05
  24. Li Liu · 1 shared paper, 2016 · strength 0.05
  25. Yiyao Zhang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.